Ilex Medical Strategic Asset Allocation Index
Ilex Medical strategic asset allocation index. Ilex Medical (ILX) has a Strategic Asset Allocation Index of 26.9% as of March 2023. Strategic assets (PP&E of ILA159.74 Million plus long-term investments of ILA-) total ILA159.74 Million, measured against net assets of ILA593.49 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Ilex Medical (ILX) tangible net worth to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Ilex Medical (2008–2022)
Strategic asset allocation index of Ilex Medical from 2008 to 2022. This chart shows how Ilex Medical's Strategic Asset Allocation Index has evolved across 15 annual periods from 2008 to 2022. As of March 2023, the index stands at 26.9%, representing strategic assets of ILA159.74 Million against net assets of ILA593.49 Million ILA.
Ilex Medical Strategic Asset Allocation Index by Year (2008–2022)
Ilex Medical strategic asset allocation index by year from 2008 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Ilex Medical from 2008 to 2022, covering 15 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Ilex Medical (ILX) market capitalisation.
| Year | SAAI | Strategic Assets (ILA) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 23.7% | ILA145.28 Million | ILA145.28 Million | ILA- | ILA613.10 Million | ▼ -2.6 pp |
| 2021 | 26.3% | ILA151.41 Million | ILA151.41 Million | ILA- | ILA575.57 Million | ▼ -8.6 pp |
| 2020 | 34.9% | ILA154.78 Million | ILA154.78 Million | ILA- | ILA443.54 Million | ▼ -1.4 pp |
| 2019 | 36.3% | ILA117.28 Million | ILA117.28 Million | ILA- | ILA323.48 Million | ▲ +16.8 pp |
| 2018 | 19.4% | ILA56.97 Million | ILA56.52 Million | ILA445.00K | ILA293.49 Million | ▼ -2.1 pp |
| 2017 | 21.5% | ILA57.28 Million | ILA56.84 Million | ILA445.00K | ILA266.15 Million | ▼ -2.6 pp |
| 2016 | 24.1% | ILA58.99 Million | ILA58.54 Million | ILA445.00K | ILA244.51 Million | ▼ -2.7 pp |
| 2015 | 26.9% | ILA60.73 Million | ILA60.29 Million | ILA445.00K | ILA225.99 Million | ▼ -1.0 pp |
| 2014 | 27.8% | ILA56.97 Million | ILA56.52 Million | ILA445.00K | ILA204.60 Million | ▲ +4.0 pp |
| 2013 | 23.8% | ILA51.10 Million | ILA50.65 Million | ILA445.00K | ILA214.38 Million | ▲ +4.6 pp |
| 2012 | 19.3% | ILA50.10 Million | ILA50.10 Million | ILA- | ILA259.96 Million | ▼ -5.0 pp |
| 2011 | 24.3% | ILA68.70 Million | ILA68.70 Million | ILA- | ILA282.99 Million | ▼ -5.9 pp |
| 2010 | 30.2% | ILA36.48 Million | ILA36.48 Million | ILA- | ILA120.80 Million | ▲ +1.8 pp |
| 2009 | 28.4% | ILA36.20 Million | ILA36.20 Million | ILA- | ILA127.32 Million | ▼ -3.4 pp |
| 2008 | 31.8% | ILA34.82 Million | ILA34.82 Million | ILA- | ILA109.44 Million | — |